跳至主要内容
临床试验/EUCTR2011-000945-19-EE
EUCTR2011-000945-19-EE进行中(未招募)1 期

A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead Sponsored Trials in Subjects with Chronic Hepatitis C Infection

Gilead Sciences Inc.0 个研究点目标入组 10,470 人开始时间: 2012年11月2日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
10,470

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Willing and able to provide written informed consent;
  • 2. Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV;
  • 3. Have achieved SVR in a Gilead-sponsored study, as defined in the original treatment protocol;
  • 4. Be willing and able to comply with the visit schedule and protocol-mandated procedures.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10000
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 470

排除标准

  • 1. Subject plans to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry.
  • 2. History of clinically-significant illness or any other major medical disorder that may interfere with subject follow-up, assessments or compliance with the protocol.

研究者

相似试验

进行中(未招募)
1 期
A long-term study to follow patients infected with chronic Hepatitis C who achieved a cure following treatment in a Gilead clinical trial.MedDRA version: 18.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsGenotype 1 Hepatitis C Virus InfectionMedDRA version: 18.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-000945-19-BEGilead Sciences Inc.10,470
进行中(未招募)
1 期
A long-term study to follow patients infected with chronic Hepatitis C who achieved a cure following treatment in a Gilead clinical trial.Genotype 1 Hepatitis C Virus InfectionMedDRA version: 18.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-000945-19-SEGilead Sciences Inc.10,470
进行中(未招募)
1 期
A long-term study to follow patients infected with chronic Hepatitis C who achieved a cure following treatment in a Gilead clinical trial.Genotype 1 Hepatitis C Virus InfectionMedDRA version: 14.0 Level: SOC Classification code 10021881 Term: Infections and infestations System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0 Level: PT Classification code 10019744 Term: Hepatitis C System Organ Class: 10021881 - Infections and infestations
EUCTR2011-000945-19-FRGilead Sciences Inc.6,607
进行中(未招募)
1 期
A long-term study to follow patients infected with chronic Hepatitis C who achieved a cure following treatment in a Gilead clinical trial.
EUCTR2011-000945-19-PLGilead Sciences, Inc.10,470
进行中(未招募)
不适用
A long-term study to follow patients infected with chronic Hepatitis C who achieved a cure following treatment in a Gilead clinical trial.Genotype 1 Hepatitis C Virus InfectionMedDRA version: 14.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2011-000945-19-HUGilead Sciences Inc.740